Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
Carfilzomib for Injection. Brands Available in India.
Carfilzomib is a targeted therapy used for treatment of multiple myeloma. Carfilzomib is classified as a Proteasome Inhibitor. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for further details.
Carfilzomib for Injection is used for the treatment of patients with multiple myeloma
Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. The U.S. Food and Drug Administration (FDA) approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.
carfilzomib for Injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of carfilzomib for Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the carfilzomib for Injection medicine cost price in India.
The order for carfilzomib for Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
KYPROLIS™ (carfilzomib) for Injection, for intravenous use Initial U.S. Approval: 2012
Generic Name: carfilzomib
For injection: 0.9 mg lyophilized powder in a single-dose vial for reconstitution and further dilution.
Carfilzomib for Injection is available.
Get In Touch
Carfilzomib for Injection suppliers in India
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand carfilzomib for Injection on prescription and Import License in Patient's Name only.
For overseas patients, carfilzomib for Injection can be made available in Send your enquiry to find carfilzomib for Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
News / Update for carfilzomib for Injection.
For KYPROLIS (carfilzomib) for Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Three-Drug Combination Improves Progression-Free Survival in Patients with Multiple Myeloma For More Details
Kyprolis (Carfilzomib) For More Details
Channel Partner In India
Delhi Office
60/4, T&T House. Yusuf Sarai,New Delhi:110016
Bangalore Office
#308, Raheja Chambers, 12,Museum Road, Bangalore 560 001
Kolkata Office
1/A R.G Kar Road, Shayambazar,Kolkata 700004
Lucknow Office
203-A, 2nd Floor, Tower -11, FelixSquare, IBB-2, Sushant Golf city, Lucknow 226030